Diagnos Laboratorium Utama Tbk. vs Gema Grahasarana Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Gema Grahasarana Tbk. trades at Rp78 (market cap 124.8B, 225.1K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.5× Gema Grahasarana Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 225.1K). Which is the better fit depends on your goals.
| DGNS | GEMA | |
|---|---|---|
Market Cap | 310.75B | 124.8B |
Volume | 963.6K | 225.1K |
Lot | 9.64K | 2.25K |
Turnover | 217.67M | 17.59M |
Average Price | 225.89 | 78.16 |
Value | 217.67M | 17.59M |
Indicative Equilibrium Price | 226 | 79 |
Indicative Equilibrium Volume | 1K | 32 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →